- Home
- GHG vs ENGN Comparison
GHG vs ENGN Comparison
Compare GHG & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHG
- ENGN
- Stock Information
- Founded
- GHG 2004
- ENGN 1999
- Country
- GHG China
- ENGN Canada
- Employees
- GHG N/A
- ENGN N/A
- Industry
- GHG Hotels/Resorts
- ENGN
- Sector
- GHG Consumer Discretionary
- ENGN
- Exchange
- GHG Nasdaq
- ENGN Nasdaq
- Market Cap
- GHG 259.8M
- ENGN 317.6M
- IPO Year
- GHG 2018
- ENGN N/A
- Fundamental
- Price
- GHG $2.51
- ENGN $5.93
- Analyst Decision
- GHG
- ENGN Strong Buy
- Analyst Count
- GHG 0
- ENGN 9
- Target Price
- GHG N/A
- ENGN $29.78
- AVG Volume (30 Days)
- GHG 13.0K
- ENGN 206.9K
- Earning Date
- GHG 02-25-2025
- ENGN 12-19-2024
- Dividend Yield
- GHG 4.00%
- ENGN N/A
- EPS Growth
- GHG N/A
- ENGN N/A
- EPS
- GHG 0.28
- ENGN N/A
- Revenue
- GHG $201,166,731.00
- ENGN N/A
- Revenue This Year
- GHG N/A
- ENGN N/A
- Revenue Next Year
- GHG $8.78
- ENGN N/A
- P/E Ratio
- GHG $8.99
- ENGN N/A
- Revenue Growth
- GHG N/A
- ENGN N/A
- 52 Week Low
- GHG $2.31
- ENGN $4.42
- 52 Week High
- GHG $4.10
- ENGN $18.40
- Technical
- Relative Strength Index (RSI)
- GHG 41.31
- ENGN 36.65
- Support Level
- GHG $2.39
- ENGN $5.60
- Resistance Level
- GHG $2.71
- ENGN $6.54
- Average True Range (ATR)
- GHG 0.10
- ENGN 0.66
- MACD
- GHG -0.01
- ENGN -0.10
- Stochastic Oscillator
- GHG 26.83
- ENGN 23.28
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.